Brookline Capital Management Predicts BIOX Q1 Earnings

Key Points

• Brookline Capital Management predicts that Bioceres Crop Solutions will report Q1 2026 earnings of ($0.03) per share, maintaining a "Hold" rating on the stock.
• Analyst estimates for the full year suggest expected earnings of ($0.05) per share, with forecasts indicating a range of quarterly earnings varying from $0.06 to ($0.07) per share in subsequent quarters.
• The stock of Bioceres Crop Solutions is currently trading at $2.06, with a consensus target price of $4.17 and a recent downgrade from Canaccord Genuity to a price target of $2.50.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Research analysts at Brookline Capital Management issued their Q1 2026 earnings per share (EPS) estimates for shares of Bioceres Crop Solutions in a research report issued to clients and investors on Tuesday, September 9th. Brookline Capital Management analyst K. Dolliver forecasts that the company will post earnings of ($0.03) per share for the quarter. Brookline Capital Management currently has a "Hold" rating on the stock. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions' Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at ($0.07) EPS and Q4 2026 earnings at ($0.07) EPS.

Several other analysts also recently issued reports on BIOX. Canaccord Genuity Group restated a "hold" rating and issued a $2.50 price target (down from $6.50) on shares of Bioceres Crop Solutions in a research note on Wednesday. Wall Street Zen upgraded Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a research report on Sunday, August 31st. Oppenheimer set a $5.00 target price on Bioceres Crop Solutions in a research report on Tuesday. Finally, Lake Street Capital cut their target price on Bioceres Crop Solutions from $8.00 to $5.00 and set a "buy" rating for the company in a research report on Wednesday. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $4.17.

Bioceres Crop Solutions Stock Performance

BIOX opened at $2.06 on Thursday. The business has a fifty day simple moving average of $3.37 and a 200 day simple moving average of $4.11. The company has a market capitalization of $129.18 million, a PE ratio of -2.54, a price-to-earnings-growth ratio of 0.96 and a beta of 0.43. Bioceres Crop Solutions has a 1 year low of $1.97 and a 1 year high of $8.93. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74.

Institutional Trading of Bioceres Crop Solutions

Several institutional investors and hedge funds have recently modified their holdings of BIOX. Stifel Financial Corp lifted its position in shares of Bioceres Crop Solutions by 51.9% during the 4th quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock worth $377,000 after buying an additional 21,168 shares during the last quarter. Northern Trust Corp acquired a new position in Bioceres Crop Solutions in the 4th quarter worth about $93,000. Bank of America Corp DE increased its holdings in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after purchasing an additional 3,735 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Bioceres Crop Solutions by 135.0% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company's stock worth $4,574,000 after purchasing an additional 432,206 shares in the last quarter. Finally, Maven Securities LTD acquired a new position in Bioceres Crop Solutions in the 4th quarter worth about $152,000. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.